Search results
Results from the WOW.Com Content Network
Treatment-emergent central sleep apnea (TECSA), also known as complex sleep apnea, is a type of sleep apnea that typically develops when a patient starts CPAP therapy for OSA. This can occur when ...
Untreated sleep apnea can lead to serious health conditions. Moderate to severe sleep apnea can increase your risk of: High blood pressure. Heart failure. Cardiovascular disease. Stroke. Fatty ...
The terms obstructive sleep apnea syndrome (OSAS) or obstructive sleep apnea–hypopnea syndrome (OSAHS) may be used to refer to OSA when it is associated with symptoms during the daytime (e.g. excessive daytime sleepiness, decreased cognitive function).
It is estimated that in the U.S., the average untreated sleep apnea patient's annual health care costs $1,336 more than an individual without sleep apnea. This may cause $3.4 billion/year in additional medical costs. Whether medical cost savings occur with treatment of sleep apnea remains to be determined. [116]
Central sleep apnea in heart failure's epidemiology is relevant, as sleep apnea and heart failure have both been associated in people with paroxysmal nocturnal dyspnea. [12] According to the study, researchers were able to conclude that ~70% of people with heart failure had breathing disorders while they slept, while half of that ~70% also ...
CPAP machines, surgery and styrofoam pillows? Sleep experts on all you need to know about sleep apnea.
Sleep apnea is measured by the apnea-hypopnea index (AHI). An AHI is determined with a sleep study. AHI values for adults are categorized as: [2] [3] Normal: AHI<5; Mild sleep apnea: 5≤AHI<15; Moderate sleep apnea: 15≤AHI<30; Severe sleep apnea: AHI≥30; An episode is when a person hesitates to breathe or stops their breathing altogether.
The conditions of hypoxia and hypercapnia, whether caused by apnea or not, trigger additional effects on the body.The immediate effects of central sleep apnea on the body depend on how long the failure to breathe endures, how short is the interval between failures to breathe, and the presence or absence of independent conditions whose effects amplify those of an apneic episode.